Cassava Sciences, Inc.

NASDAQ
SAVA
Stock
Yield per half year: -11.3%
Dividend yield: 0%
Sector: Healthcare
News
US opens criminal probe into pharma company over potential Alzheimer's drug fraud: report

19 may 07:09 US opens criminal probe into pharma company over potential Alzheimer's drug fraud: report